Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.54%
#6 Wrapped Krown Wrapped Krown +20.00%
#7 Talus Network Talus Network +19.98%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 Magma Finance Magma Finance +14.74%
Coin of the day
DeFiChain DeFiChain
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Clasificación en acciones #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Precio por acción
$0.94180721
Capitalización bursátil
$22.26M
Cambio (1 día)
0.38%
Cambio (1 año)
-14.35%
País
FR
Comercio Valbiotis SA (ALVAL)

Categoría

Healthcare
Historial del precio de la acción de Valbiotis SA (ALVAL)
Precio más alto de cierre: $0.95 el 2026-07-01

Precio más bajo de cierre: $11.52 el 2017-06-01
Historial del precio de la acción de Valbiotis SA desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -15.31%
2025 -7.34%
2024 -73.56%
2023 44.27%
2022 -51.96%
2021 6.16%
2020 207.03%
2019 -38.49%
2018 -47.84%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $49.07 -27.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $476.31 2.61%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $656.12 19.74%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $277.09 39.62%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $859.43 54.58%
NL